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1. Abbreviations 
 
ABC – avidin-biotin complex 
ACK – ammonium-chloride-potassium lysis buffer   
ACTH – adrenocorticotropic hormone 
ADAM10 – a disintegrin and metalloproteinase domain 10 
ADAM17 
(TACE) 
– a disintegrin and metalloproteinase domain 17 
tumor necrosis factor, alpha, converting enzyme 
ADRB3 – adrenoceptor beta 3 
AgRP – agouti related neuropeptide 
ARC – arcuate nucleus 
ARG1 – arginase 1 
ATGL (PNPLA2) – adipose triglyceride lipase 
ATM – adipose tissue macrophages 
ATP – adenosine triphosphate 
BAT – brown adipose tissue 
BMI – body mass index 
CART – cocaine and amphetamine regulated transcript 
CCL2 (MCP1) – chemokine (C-C motif) ligand 2; (monocyte chemotactic protein-1) 
CLS – crown-like structures 
CORT – corticosterone 
CRH – corticotropin-releasing hormone 
CX3CL1 – fractalkine  
CX3CR1 – fractalkine receptor 
DAB – 3,3'-diaminobenzidine 
DC – dendritic cell 
DGAT1 – diacylglycerol O-acyltransferase 1 
DIO – diet induced obesity 
DIO2 – type 2 iodothyronine deiodinase 
DNase – deoxyribonuclease 
EDTA – ethylenediaminetetraacetic acid 
EWAT – epididymal white adipose tissue 
FA – fatty acid 
FACS – fluorescence-activated cell sorting 
FatED – fat-enriched diet 
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GAPDH – glyceraldehyde 3-phosphate dehydrogenase 
GFP – green fluorescent protein 
GLUT4 – glucose transporter type 4 
GPAT – glycerol-3-phosphate acyltransferase 
GTT – glucose tolerance test 
H&E – hematoxylin-eosin (staining) 
HFD – high fat diet 
HRP – horse radish peroxidase 
HSD11B1 
(11βHSD1) 
– 11β-hydroxysteroid dehydrogenase type 1 
HSL (LIPE) – lipase, hormone-sensitive 
IBAT – interscapular brown adipose tissue 
IFNg – interferon gamma 
IL10 – interleukin 10 
IL1A – interleukin 1 alpha 
IL1B – interleukin 1 beta 
IL6 – interleukin 6 
KPBS – potassium phosphate buffered saline 
MD – minimal disease 
MGAT – mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-
acetylglucosaminyltransferase 
MGL – monoglyceride lipase 
MRI – magnetic resonance imaging 
mβCD – methyl-β-cyclodextrin 
NALP3 – NACHT, LRR and PYD domains-containing protein 3 
ND – normal diet 
NK cells – natural killer cells 
NLRP3 – NLR family, pyrin domain containing 3 
NPY – neuropeptide Y 
PGC1A 
(PPARGC1A) 
– peroxisome proliferator-activated receptor gamma, coactivator 1 
alpha 
PMA – phorbol-12-Myristate-13-Acetate 
PND – postnatal day 
POMC – pro-opiomelanocortin 
PPARG – peroxisome proliferator-activated receptor gamma 
qPCR – quantitative real time polymerase chain reaction 
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RIA – radioimmunoassay 
RIPA – radio-immunoprecipitation assay buffer 
RT-PCR – real-time polymerase chain reaction 
SLO – streptolysin O 
SNS – sympathetic nervous system 
SPF – specified pathogen free 
SVF – stromal vascular fraction 
SWAT – subcutaneous white adipose tissue 
T3 – triiodothyronine 
TBST – Tris buffered saline with Tween 
TH – tyrosine hydroxylase 
TNFa – tumor necrosis factor alpha 
UCP1 – uncoupling protein 1 
WAT – white adipose tissue 
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2. Introduction  
 
2.1. The obesity epidemic 
 
Overweight and obesity are defined as abnormal or excessive fat accumulation that may 
impair health. Worldwide obesity has more than doubled in the last 35 years. 39% of adults 
were overweight in 2014, and 13% were obese. Children all over the world are also affected 
by obesity and related complications [1].  Obesity affects all socioeconomic backgrounds and 
ethnicities and is a prerequisite for metabolic syndrome. Metabolic syndrome is a clustering of 
risk factors, such as central obesity, insulin resistance, dyslipidaemia and hypertension that 
together culminate in the increased risk of type 2 diabetes mellitus and cardiovascular diseases 
[2]. Obesity and overweight are associated with chronic low grade inflammation. This 
inflammatory condition plays an important part in the etiology of the metabolic syndrome and 
largely contributes to the related pathological outcomes [3]. 
Body weight can be categorized based on a persons body mass index (BMI). BMI is a person's 
weight in kilograms divided by the square of height in meters. It can be used for population 
assessment of overweight and obesity. For adults 20 years old and older, BMI is interpreted 
using standard weight status categories. These categories are: underweight (BMI < 18.5), 
normal or healthy weight (BMI 18.5 – 24.9), overweight (BMI 25.0 – 29.9), obese (BMI > 
30.0) [4]. Raised body mass index (BMI) is a major risk factor for chronic diseases such as 
cardiovascular diseases, diabetes, musculoskeletal disorders and some cancers [1] 
The mechanism of obesity development is still not fully understood, and new scientific results 
are very important to prevent and treat obesity. 
 
2.2. Energy homeostasis  
 
The fundamental cause of obesity and overweight is an energy imbalance between calories 
consumed and calories expended [1]. The brain is the main regulator of energy homeostasis, 
which controls energy intake and energy expenditure based on the signals of the internal and 
external environment [5-7]. Complex neuronal circuit within the hypothalamus and 
extrahypothalamic areas are responsible for maintaining energy homeostasis. Two distinct cell 
populations are present in the ARC. Orexigenic NPY/AgRP neurons and anorexigenic 
POMC/CART neurons are in the position to sense metabolic-related hormones and various 
nutrients and generate adequate autonomic and behavioral responses [8-10]. The autonomic 
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nervous system (which consists of two parts, the sympathetic and parasympathetic nervous 
systems) innervate peripheral metabolic tissues, including brown and white adipose tissue, 
liver, pancreas, and skeletal muscle. The the sympathetic nervous systems regulates 
thermogenesis and energy expemditure in BAT, lipid metabolism in WAT and glucose uptake 
in muscle. Sympathetic and parasympathetic nerves contribute to hepatic glucose production 
and pancreatic insulin secretion [11]. Summary of energy homeostasis is shown in Fig.1.  
Nutrients consumed and absorbed are used as fuels for energy expenditure. Excess nutrients 
are stored in the form of fat in unlimited amounts in adipose tissues, and in the form of 
glycogen, in limited amounts in liver and muscle [12]. Components of energy expenditure are 
basal metabolism, physical activity and adaptive thermogenesis. Physical activity includes all 
voluntary movements, while basal metabolism refers to biochemical processes necessary to 
sustain life. Adaptive thermogenesis is the production of heat in response to environmental 
challenges, such as exposure to cold and alterations in diet [13].  
 
 
 
Figure 1. Components of energy homeostasis.  
Brain regulates energy intake (yellow arrows) and energy expenditure (red arrows) in 
response to external and internal signals (green arrows). The fuels used for physical activity, 
basal metabolism, and adaptive thermogenesis originates from absorbed food. Excess 
nutrients are stored in adipose tissues, liver or muscles for further use (black arrows).  
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2.3. Types of adipose tissue 
 
There are two types of adipose tissue, white and brown fat, which have distinct functions. 
White adipose tissue (WAT) stores excess energy as triglycerides and displays endocrine 
functions by secreting adipokines and cytokines [14-16].  
Brown adipose tissue (BAT) is the major site of cold-, stress- and diet-induced thermogenesis 
with which BAT significantly affects systemic glucose and lipid metabolism [17-19]. 
The distribution of fat depots in humans are shown in Fig.2.  
 
Figure 2. Fat Distribution in Human.   
In human, white adipose tissue depots are found all over the body, with subcutaneous and 
intra-abdominal depots representing the main compartments for fat storage. Brown adipose 
tissue is abundant at birth and still present in adulthood but to a lesser extent.  [20] 
 
White adipocytes are spherical cells and contain one large lipid droplet. Their size mainly 
depends on the size of the lipid droplet stored in them. The lipid droplet consists of 
triglycerides and accounts for more than 90% of the cell volume. Mitochondria in white 
adipocytes are thin, elongated, and variable in amount [14]. Beyond the storage of excess fat, 
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white adipocytes have important endocrine functions. With the secretion of adipokines (e.g. 
cytokines, leptin, adiponectin), adipocytes modulates energy homeostasis and immunity [16]. 
Various WAT depots might contain inducible brown-in-white (brite, beige) adipocytes. They 
have different origin and molecular signature from classical brown adipocytes but share the 
characteristics of high mitochondria content, UCP1 expression and thermogenic capacity 
when activated. Beige adipocyte clusters are especially prominent in the subcutaneous 
inguinal WAT, and develop in response to cold and certain other stimuli. Compared with 
brown adipocytes, beige adipocytes have more phenotypic flexibility, and can acquire a 
thermogenic or storage phenotype, depending on environmental cues [21-23]. 
Brown and beige adipocytes are multilocular and contain significantly higher number of 
mitochondria than other adipocytes in the body [22]. These cells are specialized to dissipate 
energy in the form of heat by uncoupled thermogenesis, mediated by the dissociation of 
mitochondrial respiratory chain electron transport from ATP synthesis via the action of 
uncoupling protein1 (UCP1) [15].  
BAT is abundant in small mammals and in newborns and helps them to survive cold 
temperatures. In adults, it has long been considered to be absent, but recently several research 
groups demonstrated that adults have metabolically active BAT [24-28]. The amount of BAT 
is inversely correlated with body-mass index, especially in older people [29]. Metabolically 
active BAT seems to be particularly low in patients with obesity or diabetes [30]. These results 
suggest a significant role of brown adipose tissue in adult human metabolism and opens new 
opportunities to develop therapeutic interventions to treat obesity.  Table 1. shows the 
characteristics of white and brown fat.  
Both types of adipose tissues (BAT and WAT) are sensitive to environmental (temperature) - 
hormonal (T3, leptin, insulin, corticosteroid) - and metabolic (high fat diet) cues and display 
significant cellular and functional remodeling in response to these challenges. 
 
DOI:10.15774/PPKE.ITK.2017.003
11 
 
Table 1. Comparison of white and brown fat [14]. 
 White fat 
 
Brown fat 
 
Function Energy storage Heat production 
Morphology Single lipid droplet 
Variable amount of 
mitochondria 
Multiple small vacuolae 
Abundant mitochondria 
Marker protein Leptin UCP1 
Development From Myf5-negative 
progenitor cells 
From Myf5-positive progenitor 
cells (but there are also Myf5-
negative brown fat cells which 
are derived from other lineages) 
Human data Large amounts are associated 
with increased risk of obesity-
related disorders 
Large amounts are associated 
with decreased risk of obesity-
related disorders 
Impact of aging Increases with age relative to 
total body weight 
Decreases with age 
 
 
2.4. Obesity related macrophage accumulation and inflammation 
 
In addition to adipocytes, adipose tissues contains various immune-related cells including 
resident macrophages (adipose tissue macrophages – ATMs), eosinophils, mast cells and T 
cells, which significantly contribute to their function via release of (adipo)cytokines and 
transmitters in paracrine or endocrine fashion [31-34]. Macrophages are present in the highest 
percentage in the tissue (45-55%, depending on the body weight) [35]. During the 
development of obesity not only the ratio of immune cells changes but also their inflammatory 
state. Lean adipose tissue contains various anti-inflammatory immune cells, such as 
eosinophils, M2 (anti-inflammatory) macrophages, type 2 T helper (Th2) cells, invariant 
natural killer T (iNKT) cells, and regulatory T (Treg) cells. These immune cells help 
maintaining normal tissue function. In obese adipose tissue, the number of proinflammatory 
immune cells, including neutrophils, M1 (proinflammatory) macrophages, mast cells, type 1 T 
helper (Th1) cells, and CD8 T cells, are greatly elevated. Simultaneously, reduced number of 
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anti-inflammatory immune cells accelerates proinflammatory response and adipose tissue 
dysfunction (Fig. 3) [36].  
 
 
 
Figure 3. Balance of immune responses in the regulation of adipose tissue function.  
In lean adipose tissue anti-inflammatory immune cells dominate, which help maintaining 
normal tissue function. In obese adipose tissue the numbes of  immune cells are elevated and 
the number of anti-inflammatory immune cells are reduced, which leads to adipose tissue 
disfunction. [36] 
 
In the early phases of diet-induced obesity the amount of fat in adipocytes increases in visceral 
adipose tissue. Hypertrophic adipocytes change their hormone and chemokine expression, 
which leads to the increase of immune cells in the tissue. In the first days after the initiation of 
high fat diet, neutrophils infiltrate into the adipose tissue. After weeks, the numbers of natural 
killer (NK) cells and macrophages also increase. NK cells increase their number only by local 
proliferation. Increased number of macrophages originate from (at least) two distinct sources: 
local proliferation of tissue resident macrophages and/or  the infiltration of monocytes from 
the blood [37]. Infiltrated monocytes differentiate into macrophages in the tissue [38]. 
Circulating monocytes originate in the bone marrow. Experiments on bone marrow 
transplanted mice showed that after 6 weeks on a high-fat diet, 85% of the F4/80+ cells 
(macrophages) in periepididymal adipose tissue of the recipient mice were donor-derived [39], 
which indicates that these cells migrated to the adipose tissue from the circulation. 
Furthermore, in obese animals and humans the key event in the induction of adipose 
inflammation is the polarization of macrophages from anti-inflammatory (M2-like) to 
proinflammatory (M1-like) form [37, 40, 41]. M2 anti-inflammatory macrophages are 
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characterized – among others - by arginase 1, and IL10 expression. Diet-induced obesity 
decreases the expression of these genes in macrophages while increases the proinflammatory 
gene expression (TNFa, IL1, IL6) that are characteristic of M1 macrophages [42, 43]. 
Important signals to M1 polarization are interferon gamma (IFNg) secreted by NK and T cells 
and pathogen-associated molecular patterns (PAMPs) from periphery. M1 polarized 
macrophages are sensitive to a range of proinflammatory stimuli, such as leukotrienes, danger 
associated molecular patterns (DAMPs) from necrotic adipocytes, and FFA-Fetuin-A 
complexes from the periphery.  Proinflammatory cytokine expression by M1 macrophages 
leads to further accumulation of inflammatory immune cells and the amplification of 
inflammation [37]. Fig. 4. shows a summary of the development of obesity induced adipose 
tissue inflammation. 
 
 
Figure 4. Model of the development of obesity-induced adipose tissue inflammation.  
In response to high fat diet, adipocytes become hypertrophic and later hyperplastic, which is  
associated with the shift from  adiponectin to leptin/CCL2 production in adipocytes and the 
increase in the number of immune cells in visceral WAT. As obesity persists, adipocyte stress 
drives CD8+ T-cell and NK-cell activation through NKp46, resulting in local production of 
IFNg. Together with PAMPs coming from the periphery, this locally produced IFNg licenses 
adipose tissue macrophages (ATMs) toward a proinflammatory M1 state. This makes these 
cells sensitive to a range of proinflammatory stimuli, such as leukotrienes, FFA-FetuinA 
complexes, and DAMPs from necrotic adipocytes. As a result, ATMs produce proinflammatory 
cytokines, such as TNF and IL1b, and recruit more proinflammatory cells into the tissue to 
amplify the immune response. The chronic systemic presence of proinflammatory cytokines 
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derived from this response ultimately contributes to the development of insulin resistance. M1: 
M1 Macrophage; M2: M2 Macrophage; NΦ: Neutrophil; NK: natural killer cell [37]. 
 
 
Growing evidence implicates that obesity-induced tissue inflammation is not limited to the 
visceral WAT but also seen in the liver and in the hypothalamus [44]. In either tissue, diet-
induced inflammation is always associated with recruitment/proliferation and activation of 
various immune-competent cells such as monocytes, macrophages, and T cells. 
However, the accumulation of macrophages to BAT, the mechanisms that recruit and activate 
them and their effect on thermometabolic genes has not been fully elucidated. Because these 
changes contribute to insulin resistance and low grade systemic metabolic inflammation which 
is seen in a subset of obese patients with metabolic X [45], it is important to understand the 
mechanisms that recruit and activate adipose tissue macrophages and the means with which 
local inflammation affects lipid metabolism and thermoregulation. 
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2.5. Chemokines and the fractalkine-CX3CR1 system 
 
Chemokines (chemotactic cytokines) constitute the largest family of cytokines [46]. 
Chemokines and their receptors have an important role in trafficking of leukocytes during 
inflammation and immune surveillance. Furthermore they exert different functions under 
physiological conditions such as homeostasis, development, tissue repair, and angiogenesis 
but also under pathological disorders including tumorigenesis, cancer metastasis, 
inflammatory and autoimmune diseases. To date, around 50 chemokines have been identified 
in humans. Chemokines can be classified by structure or function. Four families – C, CC, 
CXC, and CX3C - are distinguished based on the arrangement of cysteine residues involved in 
the formation of disulfide bonds, and three groups based on their function: proinflammatory, 
homeostatic, and mixed [47, 48]. Most chemokines are present in soluble form mediating 
chemotaxis. CX3CL1 and CXCL16 are unique, because they can exist both membrane-bound 
and soluble form, thus besides chemotaxis they mediate cell-cell adhesion [46, 49]. 
Chemokine families and their receptors are shown in Fig. 5. 
CCL2 (MCP1) is the first discovered and most extensively studied CC chemokine; it is one of 
the key chemokines that regulate migration and infiltration of monocytes and macrophages. 
CCL2 is expressed among others by adipocytes and its circulating level correlate with 
adiposity [50, 51]. Besides CCL2, several other chemokines are also associated with obesity, 
adipose tissue macrophage infiltration, or adipose tissue inflammation. These are: CCL3, 
CCL5, CCL7, CCL8, CCL11, CCL19, CXCL1 CXCL5, CXCL8, CXCL10 and CX3CL1 [52-
56]. 
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Figure 5. Chemokine families and their receptors.  Chemokines are divided into four families 
based on the number and spacing of the conserved cysteine residues in their amino termini.  In 
CXC (alpha) chemokines (a), one amino acid separates the first two cysteine residues. In CC 
(beta) chemokines (b), the first two cysteine residues are adjacent to each other. The C 
(gamma) chemokine subfamily (c) is distinguished structurally as containing only two of the 
four conserved cysteine residues that are found in the other families. The CX3C (delta) 
chemokine subfamily, which is currently represented by a single member named fractalkine 
(CX3CL1), is characterized by the presence of three amino acids between the first two 
cysteine residues, as well as a transmembrane and mucin-like domain (d).[57]. 
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Chemokine receptors can be divided into two groups: G protein-coupled chemokine receptors, 
which signal by activating Gi-type G proteins, and atypical chemokine receptors, which 
appear to shape chemokine gradients and dampen inflammation by scavenging chemokines in 
an arrestin-dependent manner. Chemokine receptors are differentially expressed by leukocytes 
and many nonhematopoietic cells [46]. 
Fractalkine (CX3CL1/neurotactin), the only member of CX3C family, was first described in 
1997 [58, 59]. Mature membrane bound fractalkine is a 371 (mouse) or 373 (human) amino 
acid peptide with four domains: chemokine domain, mucin stalk, transmembrane domain and 
cytoplasmic domain [59-61]. The structure of fractalkine is shown in Fig. 6A. 
 
 
Figure 6. The molecular structure of fractalkine and CX3CR1 and their interaction.  
A) The structure of the membrane-bound form of fractalkine showing specific regions of the 
molecule and the site of the cleaving action of the metalloproteinases ADAM17/TACE and 
ADAM10. The unbound form of fractalkine (B), produced by metalloproteinase cleaving and 
the membrane-bound form (C) interacting with the CX3CR1 [62]. 
ADAM17/TACE and ADAM10 
metalloproteinase target 
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Cleavage of fractalkine can be homeostatic or induced (with PMA, mβCD, SLO, or 
ionomycin), mediated by ADAM10 (the majority of constitutive, and ionomycin-induced 
shedding) and ADAM17 metalloproteinases [63] resulting a soluble molecule. ADAM17 
(TACE) is also responsible for the regulation of the proteolytic release of other chemokines, 
cytokines, growth factors and their receptors, including TNFa, TNF receptors I and II, TGFa, 
l-selectin, IL6, and M-CSF receptor 1. Fractalkine shedding by ADAM17 is increased in a 
variety of diseases such as diabetes, atherosclerosis, ischemia, heart failure, arthritis, cancer, 
neurological and immune diseases [64]. Elevated  mRNA expression of Adam17 was found in 
epididymal fat [65], and in subcutaneous fat [66] of HFD fed obese mice. These results 
suggest that fractalkine shedding is correlated with TNFa release in various diseases.  
Fractalkine is expressed in numerous organs, such as brain, lung, kidney, intestines, pancreas, 
adipose tissue, liver in homeostatic state and it is upregulated in inflammatory conditions. 
Neurons, epithelial cells, endothelial cells, smooth muscle cells, adypocytes have shown to 
express fractalkine [56, 59, 67-71].  
Analysis of CX3CR1 expression in CX3CR1+/gfp mice showed GFP/CX3CR1 positivity in 
the following cells: peripheral blood monocytes (CD11b+ and Gr1low), a subset of natural killer 
(NK) cells (5 to 30% of all NK cells), subsets of both CD8α− (so-called myeloid) and CD8α+ 
(lymphoid) dendritic cells (DCs), macrophages. Within the brain, microglia (the brain resident 
macrophage population) express fractalkine receptor [67, 72, 73].  CX3CR1 - belongs to the 
class of metabotropic receptors, also known as G protein-coupled receptors, or seven-
transmembrane proteins. [74]. The receptor is coupled to Gi and Gz subtypes of G proteins 
[75]. The structure of CX3CR1 and its interaction with fractalkine is shown in Fig. 6B-C. 
CX3CR1 activation by fractalkine have been shown to induce multiple signal transduction 
pathways leading to elevation of cytosolic free calcium and modifications in enzymes, ion 
channels, transcriptional activators, and transcriptional regulators [76-80]. Fractalkine 
signaling eventually participates in the adhesion, chemotaxis and survival of the cells 
expressing CX3CR1 [80]. Fig. 7. shows the model of fractalkine dependent migration of 
leukocytes. 
Fractalkine is an important regulatory factor of microglia activity in the central nervous 
system where it mediates neuroinflammation. However, its role in metabolic inflammation in 
general, and in connecting metabolic and neuroinflammation in particular, remains to be 
elucidated. It has recently been shown that fractalkine is an adipocytokine in humans [56]. 
Furthermore, elevated plasma fractalkine levels were detected in patients with type 2 diabetes 
and single nucleotide polymorphism (rs3732378) in CX3CR1 was associated with changes in 
adipose markers and metabolic parameters [56]. 
DOI:10.15774/PPKE.ITK.2017.003
19 
 
 
 
Figure 7. Schematic model of fractalkine-mediated pathways in the adhesion cascade.  
Fractalkine is expressed on endothelial cells as the membrane-bound form and captures 
CX3CR1 expressing leukocytes in a selectin- and integrin-independent manner. Interaction 
between fractalkine and CX3CR1 can also increase integrin avidity, resulting in firmer 
adhesion. CX3CR1 expressing leukocytes then extravasate through the vascular wall into the 
tissue to a chemokine gradient. Fractalkine may facilitate extravasation of circulating 
CX3CR1 expressing leukocytes by mediating cell adhesion through the initial tethering and 
final transmigration steps [81]. 
 
The role of fractalkine – CX3CR1 signaling in cardiovascular diseases (such as 
atherosclerosis), rheumatoid arthritis, other inflammatory diseases and cancer is well described 
[80, 82], however its function in obesity is not fully known. Furthermore, it is not known 
whether fractalkine – CX3CR1 signaling has a role in BAT inflammation and/or function. 
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3. Aims 
 
My aims were  
(I) to identify the role of fractalkine/CX3CR1 signaling in the recruitment and activation 
of immune cells in key central (hypothalamus) and peripheral (visceral WAT, 
BAT and liver) structures in obesity and,  
(II)  to reveal the role of obesity-related, fractalkine – CX3CR1 dependent, local 
inflammation in regulation of triglyceride- and thermo-metabolism in BAT of 
obese mice. 
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4. Materials and methods 
 
4.1. Animals and diet 
 
Experiments were performed in male CX3CR1 +/gfp (+/gfp), and CX3CR1 gfp/gfp (gfp/gfp) 
mice [83]. Animals were obtained from the European Mouse Mutant Archive (EMMA 
CX3CR1tm1Litt MGI:2670351). In these mice, the Cx3cr1 gene was replaced by a Gfp reporter 
gene such that heterozygote CX3CR1 +/gfp mice express GFP and retain receptor function in 
CX3CR1 expressing cells, whereas homozygote CX3CR1 gfp/gfp mice are labeled with GFP 
and lack functional CX3CR1. Genotype of the animals has been verified by PCR using 
combination of three different primers as described by Jung et al [83].  
The background C57Bl/6J strain has been shown to be genetically vulnerable to diet-induced 
obesity [84].   
Animals were housed in groups of 4-5/cage at the minimal disease (MD) level of the Medical 
Gene Technology Unit of our Institute, had free access to food and water and were maintained 
under controlled conditions: temperature, 21 °C ± 1 °C; humidity, 65%; light-dark cycle, 12-h 
light/12-h dark cycle, lights on at 07:00. 5-14 weeks old mice, both CX3CR1 +/gfp (n=25) and 
CX3CR1 gfp/gfp (n=25) mice were randomly distributed into two groups. The first group, 
normal diet (ND), received standard chow (VRF1 (P), Special Diets Services (SDS), Witham, 
Essex, UK.). The second group received fat-enriched diet (FatED), by providing a 2:1 mixture 
of standard chow and lard (Spar Budget, Budapest, Hungary). The energy content and 
macronutrient composition of the two diets is given in Table 2. All procedures were conducted 
in accordance with the guidelines set by the European Communities Council Directive (86/609 
EEC) and approved by the Institutional Animal Care and Use Committee of the Institute of 
Experimental Medicine (permit number: 22.1/3347/003/2007). 
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Table 2. Energy content and macronutrient composition of diets  
 
ND - standard chow FatED - mixed chow 
 
g% kcal% g% kcal% 
Protein 19,1 22,5 12,7 9,7 
Carbohydrate 55,3 65,0 36,9 28,0 
Fat 4,8 12,6 36,5 62,3 
     
kcal/g 3,40 5,27 
 
 
4.2. Experimental design 
 
Mice were fed with normal diet (ND) or fat enriched diet (FatED) for 10 weeks, body weight 
and food consumption was measured weekly. In the 10th week, glucose tolerance test (GTT) 
was performed after overnight fasting. Two days after the GTT, mice were decapitated, trunk 
blood was collected on EDTA, and the plasma stored at -20°C until assay. Brain, liver, 
visceral- and, subcutaneous white adipose tissue pads and interscapular brown adipose tissue 
were collected, sampled and stored at -70°C for RT-PCR, or fixed in 4% buffered 
paraformaldehyde for histology. A separate set of animals underwent cold tolerance test. Body 
composition was assessed on another set of animals. 
 
4.3. Body composition analysis  
 
Body composition was determined using EchoMRI™ Body Composition Analyzer 
(EchoMRI, Houston, TX, USA). Mice were scanned weekly. Two scans were performed per 
animal and the average was used for analysis. Body fat composition was calculated by 
determining total fat (g) divided by total body weight (g) and expressed as a percentage. 
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4.4. Glucose tolerance test 
 
Mice were fasted overnight (15 h) and then injected intraperitoneally with 2 mg/g of body 
weight D-glucose (20% stock solution in saline). Blood glucose was measured from tail vein 
by DCont Personal Blood Glucose Meter (77 Elektronika Kft. Hungary) at 0 min (just before 
glucose injection) and at 15-, 30-, 60-, 90- and 120-min intervals after the glucose load. 
 
4.5. Hormone and cytokine measurements 
 
Plasma adrenocorticotrophic hormone (ACTH) and corticosterone (CORT) concentrations 
were measured by radioimmunoassay (RIA). ACTH RIA was developed in our laboratory [85] 
using an antibody (#8514) raised against the mid-portion of human ACTH1-39. The test uses 
50 µl of plasma per determination, has a lower limit of sensitivity of 0.1 fmol/ml, and the 
average intra-and inter-assay coefficients of variation are 4.8% and 7.0% respectively. Plasma 
corticosterone has been measured by a direct RIA without extraction as described [86]. The 
intra and interassay %CVs in this assay are 12.3 and 15.3 respectively. 
Plasma cytokine levels were measured by ELISA using DuoSet ELISA kits for IL1a, IL1b and 
IL6 (R&DSystems, Minneapolis, MN, USA) according to the manufacturer’s protocol.  
 
4.6. Histology and quantitative analysis 
 
Tissue samples were immersion fixed in 4% w/v paraformaldehyde in 0.1 mol l–1 phosphate 
buffer, pH 7.4 (PB) for 3 days and stored in 1% w/v paraformaldehyde in 0.1 mol l–1 PB at 
4°C then were embedded in paraffin, sectioned and stained with hematoxylin-eosin (H&E). 
Microscopic slides were digitalized with Pannoramic Digital Slide Scanner (3DHISTECH 
Kft., Hungary). WAT adipocyte cell areas and, lipid droplet number and size of brown adipose 
cells were counted under 40x magnification in one field of view with ImageJ software (NIH, 
USA). In WAT samples of FatED groups all adipose cells (60-80), while in ND groups 
maximum 150 cells were analyzed per field. In BAT 31 cells and 401-823 droplets were 
analyzed per animal. 
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4.7. Immunohistochemistry 
 
F4/80 (murine macrophage marker) staining on paraffin-embedded tissue sections was 
performed by standard immunohistochemical protocol. Slides were deparaffinized and 
rehydrated then antigen retrieval was performed with proteinase K (10 mg/ml; diluted to 1:25 
in 1 M Tris buffer pH=8.0). Endogenous peroxidase was blocked by 0.3% H2O2. After washes 
in KPBS, nonspecific binding was blocked by 2% normal rabbit serum for 1 hour. The 
sections were incubated in anti-mouse F4/80 antibody made in rat (BMA Biomedicals, 1:50) 
overnight at 4°C. Following KPBS (0.01M potassium phosphate buffer, 0.154 M NaCl pH 
7.4) washes (4 x 5 min), slides were incubated for 1 hour in biotinylated rabbit anti-rat 
antibody (Vector Laboratories; 1:250). After rinsing in KPBS, avidin biotin amplification was 
performed with a Vectastain Elite ABC kit (Vector Laboratories) and immunoreactivity was 
visualized by nickel-enhanced diaminobenzidine (DAB-Ni) substrate. Sections were analyzed 
with Nikon Eclipse E600 microscope under 20x magnification in 5 fields of view per section.  
Fluorescent F4/80 labeling was performed on 1 mm3 BAT blocks fixed in 4% w/v 
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4), and stored in cryoprotectant solution at 
-20°C.  Tissue blocks were treated with 2% normal rabbit serum then incubated in rat anti-
mouse F4/80 antibody (BMA Biomedicals; 1:50) overnight at 4°C.  The antigens were then 
visualized by biotinylated rabbit anti-rat IgG (Vector Laboratories; 1:500) for 100 minutes 
followed by streptavidin Alexa 594 (Molecular Probes; 1:500) for 100 minutes. Images were 
taken using a Nikon C2 confocal microscope, at 60x magnification. 
 
4.8. Core body temperature measurement and cold challenge 
 
Rectal temperature was measured with Multithermo thermometer (Seiwa Me Laboratories 
Inc., Tokyo, Japan). To assess cold tolerance, set of animals (N = 30) from both genotypes 
were fasted for 5 hours, then placed into new individual cages with minimal bedding and 
transferred to cold room (4oC).  Rectal temperature was measured immediately before and 60, 
120, 180 and 240 min after cold exposure. 
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4.9. Gene expression analysis by quantitative real-time PCR 
 
Total RNA was isolated from tissue samples with QIAGEN RNeasyMiniKit (Qiagen, 
Valencia, CA, USA) according the manufacturer’s instruction. To eliminate genomic DNA 
contamination, DNase I (Fermentas) treatment was used. Sample quality control and 
quantitative analysis were carried out by NanoDrop (Thermo Scientific). cDNA synthesis was 
performed with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA, USA). The designed primers (Invitrogen) were used in real-time PCR 
reaction with Power SYBR Green PCR master mix (Applied Biosystems, Foster City, CA, 
USA) on ABI StepOnePlus instrument. The gene expression was analyzed by ABI StepOne 
2.3 program. The amplicon was tested by Melt Curve Analysis. Measurements were 
normalized to ribosomal protein S18 (Rps18) expression [87]. Amplification was not detected 
in the RT-minus controls. 
 
4.10. Primer design 
 
Primers used for the comparative CT (threshold cycle) experiments were designed by the 
Primer Express 3.0 program. Primer sequences are shown in Table 3. 
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Table 3. Mouse specific primer sequences used for rtPCR 
Gene Forward sequence Reverse sequence 
Adrb3 ACCGCTCAACAGGTTTGA GGGGCAACCAGTCAAGAAGAT 
Arg1 GTCTGGCAGTTGGAAGCATCT GCATCCACCCAAATGACACA 
Atgl GCCATGATGGTGCCCTATACT TCTTGGCCCTCATCACCAGAT 
Ccl2 (Mcp1) CCAGCACCAGCACCAGCCAA TGGATGCTCCAGCCGGCAAC 
Crh CGCAGCCCTTGAATTTCTTG CCCAGGCGGAGGAAGTATTCTT 
Cx3cl1 CCGCGTTCTTCCATTTGTGT GGTCATCTTGTCGCACATGATT 
Dgat1 GTTTCCGTCCAGGGTGGTAGT CGCACCTCGTCCTCTTCTAC 
Dio2 ACAAACAGGTTAAACTGGGTGAAG CGTGCACCACACTGGAATTG 
Gapdh TGACGTGCCGCCTGGAGAAA AGTGTAGCCCAAGATGCCCTTCAG 
Gfp GGACGACGGCAACTACAAGA AAGTCGATGCCCTTCAGCTC 
Glut4 AGGAACTGGAGGGTGTGCAA GGATGAAGTGCAAAGGGTGAG 
Gpat AGTGAGGACTGGGTTGACTG GCCTCTTCCGGCTCATAAGG 
Hsd11b1 CCTCCATGGCTGGGAAAAT AAAGAACCCATCCAGAGCAAAC 
Hsl AGCCTCATGGACCCTCTTCTA TCTGCCTCTGTCCCTGAATAG 
Il10 AGTGAGAAGCTGAAGACCCTCAGG TTCATGGCCTTGTAGACACCTTGGT 
Il1a CCATAACCCATGATCTGGAAGAG GCTTCATCAGTTTGTATCTCAAATCAC 
Il1b CTCGTGGTGTCGGACCCATATGA TGAGGCCCAAGGCCACAGGT 
Il6 CTCTGCAAGAGACTTCCATCC AGTCTCCTCTCCGGACTTGT 
Mgat TGGTTCTGTTTCCCGTTGTTC GAAACCGGCCCGTTACTCAT 
Mgl CTTGCTGCCAAACTGCTCAA GGTCAACCTCCGACTTGTTCC 
Nlrp3 CAGAGCCTACAGTTGGGTGAA ACGCCTACCAGGAAATCTCG 
Npy CAGATACTACTCCGCTCTGCGACACTACAT TTCCTTCATTAAGAGGTCTGAAATCAGTGT 
Pgc1a  ATGTGCAGCCAAGACTCTGT TTCCGATTGGTCGCTACACC 
Pomc TGCTTCAGACCTCCATAGATGTGT GGATGCAAGCCAGCAGGTT 
Pparg2 CTCCTGTTGACCCAGAGCAT TGGTAATTTCTTGTGAAGTGCTCA 
Rps18 TCCAGCACATTTTGCGAGTA TTGGTGAGGTCGATGTCTGC 
Th TCTCAGAGCAGGATACCAAGCA GCATCCTCGATGAGACTCTGC 
Tnfa CAGCCGATGGGTTGTACCTT GGCAGCCTTGTGCCTTGA 
Ucp1 GGTCAAGATCTTCTCAGCCG AGGCAGACCGCTGTACAGTT 
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4.11. Normalized Gfp expression 
 
Because the coding region of the Cx3cr1 gene has been replaced by Gfp in experimental 
animals [83], I relied on Gfp expression to estimate and compare Cx3cr1 gene expression in 
CX3CR1 homo-(gfp/gfp) and heterozygote (+/gfp) animals. To resolve different Gfp copy 
numbers in homo- and heterozygotes, normalized Gfp expression was calculated using the 
following formula: RQ / CN, where RQ is the relative quantity of Gfp from real time qPCR 
measurement and CN is the Gfp copy number determined from genomic DNA by Taqman 
Copy Number Assay.  
 
4.12. Western blot analysis 
 
BAT samples were homogenized by Bertin Minilys homogenizer in RIPA buffer (50mM Tris 
- 150mM NaCl – 1% Triton X-100 – 0,5% Na deoxycholate - 0,1% SDS pH=8.0) 
supplemented with protease inhibitor cocktail tablet (Complet Mini per 10 ml, Roche). Protein 
samples (20 μg) were separated by electrophoresis on 12% SDS gel at 120 V for 2 h and 
transferred to Hybond-ECL membrane (Amersham Life Science) by semi-dry transfer (Trans 
Blot SD Cell, Biorad). The transfer was carried out at 24 V for 60 min using ice cold transfer 
buffer (20mM Tris – 190mM Glycine – 20% Methanol pH=8.3). The membrane was 
incubated for 1 h in blocking buffer (1xTBST:154mM Trizma base – 1,37M NaCl - 0.05% 
Tween-20 pH=7.6 and 5% non-fat dry milk). After incubation, the membrane was cut between 
49kDA and 37kDA marks (Benchmark pre-stained protein ladder, Invitrogene). Thereafter, 
membranes were probed either by rabbit anti-UCP1 antibody (1:1000, Abcam) or mouse 
monoclonal anti-b-tubulin antibody (1:2000; Proteintech).  Both membranes were washed 
three times for 5 min in 1 × TBST before 1h incubation in buffer (1 × TBS, 0.05% Tween-20) 
containing biotinylated anti-rabbit IgG (1:5000, Vector) or HRP conjugated anti-mouse IgG 
(1:4000, Sigma) respectively. Membrane, containing UCP1, was incubated 1h in avidin-biotin 
horseradish peroxidase complex (Vectastain Elite ABC Peroxidase Kit, Vector). Afterwards 
both membranes were developed by immunoperoxidase reaction. Images were acquired by 
Chemi Genius 2 Bioimaging System (Syngene) and analyzed using ImageJ software. UCP1 
values were normalized to those for tubulin. 
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4.13. Stromal Vascular Fraction preparation and Flow Cytometry 
 
Epididymal white fat pads have been dissected from mice after decapitation. Fat tissue was 
minced into small pieces and digested in Krebs-Ringer HEPES (KRH) buffer (pH=7.4) 
containing 1% BSA and 1mg/ml Collagenase (SIGMA C9891) at 37oC for 30 min in shaking 
bath and then filtered through a 40 µm mesh. The cell suspension was centrifuged at 500x g 
for 10 min. to separate floating adipocytes and stromal vascular cell fraction (SVF) in the 
pellet. SVF was resuspended in KRH-BSA buffer. Following lysis of red blood cells with 
ACK solution and Fc receptor blockade (anti-mouse CD16/CD32, clone 93, eBioscience), 
cells were labelled with cocktails of selected antibodies: MHCII-APC, Ly6c-PE-Cy7, CD115-
APC (eBioscience) and F4/80-PE (Serotec). Specificity of antibodies has been assessed by 
eBioscience and Serotec, respectively. Cells were acquired on a FACSAria II flow cytometer 
(BD Biosciences, US) and data were analyzed using FACS Diva software (BD Biosciences). 
 
4.14. Statistical analysis 
 
Statistical analysis was performed by factorial ANOVA with Newman–Keuls post-hoc test in 
Statistica 11 (StatSoft Inc.). Flow cytometric data were analyzed by two-way ANOVA 
followed by Sidak’s multiple comparison test (GraphPad Prism). The results are shown as 
means ± SEM. Main effects of ANOVA are presented in the text, the post-hoc results are 
shown in the graphs. If the main effect was significant, but the post-hoc did not show 
differences, the main effects are shown in the graph. In all cases p < 0.05 was considered 
significant. 
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5. Results 
5.1. Fractalkine – CX3CR1 signaling is necessary for the development of the 
characteristics of obesity 
 
5.1.1. Body weight gain, body fat gain 
 
To investigate the role of fractalkine – CX3CR1 signaling in the development of obesity, mice 
with intact (CX3CR1 +/gfp) or impaired (CX3CR1 gfp/gfp) fractalkine signaling were fed 
with ND or FatED for 10 weeks. Body weight gain, food and energy intake and, fecal output 
was monitored regularly.  
Body weight gain became significant from the 5th week in response to FatED. Alhough the 
body weight elevated in both genotypes, it was statistically significant only in +/gfp FatED 
mice (Fig. 8A). (Factorial ANOVA: W5 diet effect: F(1,46) = 10.40, p < 0.01; W6 diet effect: 
F(1,46) = 11.73, p < 0.01; W7 diet effect: F(1,46) = 15.85, p < 0.001; diet*genotype: F(1,46) = 
4.28, p < 0.05; W8 diet effect: F(1,46) = 18.53, p < 0.001; genotype effect: F(1,46) = 4.86, p < 
0.05; diet*genotype: F(1,46) = 4.29, p < 0.05; W9 diet effect: F(1,46) = 23.37, p < 0.001; 
genotype effect: F(1,46) = 4.99, p < 0.05; diet*genotype: F(1,46) = 4.67, p < 0.05; W10 diet 
effect: F(1,46) = 26.38, p < 0.001; diet*genotype: F(1,46) = 6.03, p < 0.05) 
The increased body weight gain might be the result of elevated energy intake, elevated energy 
harvest from food or decreased energy expenditure. I did not find differences in food and 
energy intake or feces amount between genotypes (Table 4-6).  
Although the daily food consumption and feces amount of all FatED mice was lower, the daily 
energy intake was comparable to those that are on normal diet. Because there were no 
significant genotype effect in above mentioned parameters, these factors may not be 
responsible for the differences seen in body weight gain. 
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Figure 8. Fractalkine signaling contributes to weight gain in FatED fed mice.  
A) Weight gain in control (CX3CR1 +/gfp) and fractalkine receptor deficient (CX3CR1 
gfp/gfp) mice during 10 weeks of ND or FatED. N = 12-13 per group. B) Change in body fat% 
measured by EchoMRI. N = 3-4 per group. Mean ± SEM values, * p < 0.05; ** p < 0.01; *** 
p < 0.001 vs. ND, # p < 0.05; ## p < 0.01; ### p < 0.001  vs. +/gfp (Newman-Keuls post-hoc 
comparison). FatED – fat enriched diet, ND – normal diet. 
 
EchoMRI showed that body weight gain in FatED fed mice was the result of body fat gain 
(Fig. 8B). 
 
5.1.2. Fat depots 
 
By analyzing fat depots I found that the relative weight of  EWAT – which is responsible for 
fat storage – and BAT – which participates in energy expenditure by thermogenesis – was 
increased in response to FatED, but it was significantly lower in gfp/gfp mice (Fig. 9A-B) 
(EWAT: diet effect: F (1,28) = 34.90, p < 0.001; genotype effect: F(1,28) = 5.75, p < 0.05; 
diet*genotype: F (1,28) = 4.30, p < 0.05; BAT: (diet effect: F (1,28) = 27.52, p < 0.001).  
Relative liver weight was lower in FatED fed mice, but there were no differences between 
genotypes (Fig.9C) (diet effect: F (1,14) = 71.10, p < 0.001).  
 
A) 
B) 
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Figure 9.  Adipose tissue and liver weights are affected by fractalkine signaling in FatED 
fed mice. Normalized organ weights are shown as % of body weight. A) EWAT, N = 7-9 per 
group. B) BAT, N = 8-9 per group. C) Liver, N = 4-5 per group. Mean ± SEM values, * p < 
0.05; ** p < 0.01; *** p < 0.001 vs. ND, # p < 0.05; ## p < 0.01; ### p < 0.001  vs. +/gfp 
(Newman-Keuls post-hoc comparison). FatED – fat enriched diet, ND – normal diet. 
 
Table 4. Daily food intake (g) / mouse.  
  Weeks 
Genotype Diet 1 2 3 4 5 6 7 8 9 10 
+/gfp ND 3,41 ± 
0,58 
4,63 ± 
0,28 
3,97 ± 
0,37 
4,52 ± 
0,14 
4,45 ± 
0,15 
3,69 ± 
0,15 
7,33 ± 
0,37 
3,99 ± 
0,34 
4,9 ± 
0,26 
3,31 ± 
0,36 
 FatED 2,88 ± 
0,11 
3,38 ± 
0,11* 
2,58 ± 
0,1   ** 
2,83 ± 
0,08 
*** 
2,84 ± 
0,18 
*** 
3,24 ± 
0,16 
3,17 ± 
0,15 
*** 
3,03 ± 
0,1 
3,02 ± 
0,16 
*** 
3,53 ± 
0,24 
gfp/gfp ND 3,53 ± 
0,53 
5,75 ± 
0,79 # 
4,14 ± 
0,15 
4,69 ± 
0,36 
4,44 ± 
0,27 
4,23 ± 
0,35 
6,62 ± 
0,11 
4,38 ± 
0,8 
5,15 ± 
0,16 
4,1 ± 
0,26 
 FatED 2,7 ± 
0,09 
3,25 ± 
0,19 ** 
2,68 ± 
0,19 ** 
2,88 ± 
0,22 
*** 
2,74 ± 
0,08 
*** 
3,32 ± 
0,23 * 
3,07 ± 
0,19 
*** 
2,9 ± 
0,13 * 
2,94 ± 
0,16 
*** 
3,37 ± 
0,14 
Mean ± SEM values. * p < 0.05; ** p < 0.01; *** p < 0.001 vs. ND; # p < 0.05 vs. +/gfp (Newman-Keuls 
post-hoc comparison). N = 4-5 per group. 
 
 
A) B) C) 
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Table 5. Daily energy intake (kcal) / mouse.  
  Weeks 
Genotype Diet 1 2 3 4 5 6 7 8 9 10 
+/gfp ND 11,59 ± 
1,99 
15,74 ± 
0,96 
13,5 ± 
1,26 
15,4 ± 
0,5 
15,13 ± 
0,53 
12,55 ± 
0,51 
24,93 ± 
1,26 
13,59 ± 
1,15 
16,66 ± 
0,89 
11,27 ± 
1,25 
 FatED 15,14 ± 
0,6 
17,82 ± 
0,62 
13,6 ± 
0,53 
14,92 ± 
0,46 
14,95 ± 
0,98 
17,07 ± 
0,85 
16,69 ± 
0,83*** 
15,95 ± 
0,53 
15,92 ± 
0,86 
18,56 ± 
1,27** 
gfp/gfp ND 12,01 ± 
1,82 
19,56 ± 
2,68 
14,08 ± 
0,53 
15,95 ± 
1,23 
15,09 ± 
0,94 
14,38 ± 
1,22 
22,5 ± 
0,37 
14,91 ± 
2,74 
17,52 ± 
0,55 
13,94 ± 
0,89 
 FatED 14,2 ± 
0,52 
17,13 ± 
1 
14,09 ± 
1,05 
15,14 ± 
1,16 
14,45 ± 
0,43 
17,5 ± 
1,21 
16,17 ± 
1,03** 
15,28 ± 
0,7 
15,5 ± 
0,88 
17,73 ± 
0,77 * 
Mean ± SEM values, ** p < 0.01; *** p < 0.001 vs. ND (Newman-Keuls post-hoc comparison). N = 4-5 
per group. 
 
Table 6. Daily fecal output (g) / mouse.  
  Weeks 
Genotype Diet 1 3 4 6 7 8 
+/gfp ND 0,93 ± 0,04 0,93 ± 0,04 0,85 ± 0,04  0,89 ± 0,02 0,99 ± 0,07 
 FatED 0,52 ± 0,04*** 0,54 ± 0,02*** 0,47 ± 0,03*** 0,51 ± 0,03 0,42 ± 0,01*** 0,44 ± 0,02*** 
gfp/gfp ND 0,95 ± 0,03 0,91 ± 0,08 0,81 ± 0,03  0,96 ± 0,16### 1,02 ± 0,03 
 FatED 0,51 ± 0,01*** 0,55 ± 0,02*** 0,49 ± 0,02*** 0,51 ± 0,02 0,43 ± 0,01*** 0,48 ± 0,01*** 
 
Mean ± SEM values, *** p < 0.001 vs. ND, ### p < 0.001 vs. +/gfp (Newman-Keuls post-hoc 
comparison). N = 4-5 per group. 
 
5.1.3. Glucose intolerance 
 
Obesity is often associated with glucose intolerance, which was observed following GTT in 
+/gfp FatED mice but not in gfp/gfp FatED group. During the first 60 minutes after glucose 
load, there were no differences between groups. However after 120 minutes, blood glucose 
levels returned to normal in ND groups and gfp/gfp FatED fed mice, but not in +/gfp FatED 
group (diet effect: F (1,14) = 8.51, p < 0.05; diet*genotype: F (1,14) = 5.10, p < 0.05)  (Fig. 
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10B). Fasting blood glucose levels were similar in all groups, which means that 10 weeks of 
FatED did not cause severe dysregulation in carbohydrate metabolism (Fig. 10A).  
 
 
Figure 10. Effects of fat enriched diet on glucose homeostasis 
A) Fasting blood glucose levels (N = 4-5 per group). B) Blood glucose levels in response to ip. 
glucose load during glucose tolerance test.  CX3CR1 gfp/gfp mice kept on fat-enriched diet 
did not develop glucose intolerance (N = 4-5 per group).  * p < 0.05 vs. ND,  # p < 0.05, ## p 
< 0.01 vs. +/gfp (Newman-Keuls post-hoc comparison). FatED – fat enriched diet, ND – 
normal diet. 
 
5.1.4. Cold tolerance 
 
Cold tolerance test was performed to examine the thermogenic ability of mice. The core 
temperature at the beginning of the test was not statistically different between groups (Fig. 
11A), although it seems to be lower in FatED groups. When mice were placed to cold, the 
rectal temperature of all mice gradually decreased. However, after 2 hours in cold, the 
temperature of homozygous animals started to increase back to the normal and the increase in 
FatED mice was significantly higher than that seen in heterozygous animals fed by control- or 
FatED (genotype effect: F (1,26) = 4.75, p < 0.05). It should be noted that the decrease in body 
temperature in +/gfp mice seems to be lower in FatED group than in ND group, but it is not 
statistically significant (Fig. 11B-C). 
A) B) 
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Figure 11. Body temperatures in various temperatures. A) Core body temperature at room 
temperature. B-C) Changes in body temperature during cold tolerance test. (N = 13 in ND 
groups and N = 3 in FatED groups). * p < 0.05 vs. ND, # p < 0.05 vs. +/gfp (Newman–Keuls 
post hoc comparison). FatED – fat enriched diet, ND – normal diet. 
5.1.5. Elevated plasma cytokine concentrations 
 
Plasma IL1b showed an increase in response to FatED overall (genotype effect: F (1, 12) 
=17.35, p < 0.05). However, post hoc comparison revealed that only +/gfp mice fed a fat-
enriched diet showed significant increase in plasma IL1b compared to normal diet, but not 
gfp/gfp animals. Plasma IL1a and IL6 levels were not significantly different in any 
experimental groups (Figure 12). 
 
Figure 12. Plasma IL1b is upregulated in response to fat enriched diet in +/gfp, but not in 
gfp/gfp mice 
IL1b, IL1a and IL6 levels were measured from plasma samples with ELISA after 10 weeks of 
FatED or ND. N = 4-5 per group. **p < 0.01 vs. ND, # p < 0.05 vs. +/gfp (Newman–Keuls 
post hoc comparison). FatED – fat enriched diet, ND – normal diet. 
 
# 
A) B) C) 
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5.1.6. Hypothalamo-pituitary-adrenocortical (HPA) axis 
 
Because the neuroendocrine stress axis has been implicated in central metabolic and immune 
regulation, I assessed corticotropin-releasing hormone (Crh) mRNA levels in the 
hypothalamus and adrenocorticotropin (ACTH) and corticosterone concentration in the 
plasma.   In the hypothalamus there were no significant differences in Crh mRNA levels, 
although a trend towards CX3CR1 gfp/gfp mice having slightly elevated Crh levels was seen 
(not significant, (F (1,14) = 3.15, p = 0.09) (Fig. 13A)). 
Plasma ACTH levels were higher in FatED fed mice than in controls (F (1,13) = 7.35, p < 
0.05) (Fig. 13B).  
Gfp/gfp mice had higher plasma corticosterone levels compared to heterozygotes (+/gfp) (F 
(1,12) = 5.30, p < 0.05) (Fig. 13C). The diet was without any significant effect on plasma 
corticosterone levels. 
 
 
Figure 13. Effect of fat-enriched diet on the activity of the hypothalamo-pituitary-
adrenocortical axis 
A) Mean ± SEM values of relative Crh mRNA levels in the hypothalamus.  B) Plasma ACTH-
levels  * p < 0.05 between ND and FatED groups (diet effect). C) Plasma corticosterone levels 
* p < 0.05 between gfp/gfp and +/gfp groups (genotype effect). N = 4-5 per group. FatED – 
fat enriched diet, ND – normal diet. 
A) B) C) 
diet * genotype * 
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5.2. Fractalkine – CX3CR1 signaling dependent adipose tissue remodeling 
 
Histological analysis showed that adipocytes in EWAT and SWAT were enlarged in both 
FatED groups, but their size was smaller in gfp/gfp mice (Fig. 14) (EWAT: diet effect F 
(1,1716) = 1403.58, p < 0.001; genotype effect F (1,1716) = 104.38, p < 0.001; diet*genotype  
F (1,1716) =116.00, p < 0.001; SWAT: diet effect F (1,2546) = 1099.63, p < 0.001; genotype 
effect F (1,2546) = 43.60,  p < 0.001; diet*genotype F (1,2546) = 36.00, p < 0.001).  
 
 
Figure 14. Effect of fat-enriched diet on different fat depots    
A-B) Mean ± SEM values of adipocyte areas measured in EWAT and SWAT samples of 
CX3CR1 gfp/gfp, and +/gfp animals kept on normal or FatED (N = 4-5 per group). (C) 
Representative histological images of hematoxylin-eosin stained EWAT sections. Scale bar = 
100 μm. *** p < 0.001 vs. ND,  ###  p < 0.001 vs. +/gfp (Newman-Keuls post-hoc 
comparison).  FatED – fat enriched diet, ND – normal diet. 
 
As shown in Fig. 15A, fat enriched diet resulted in “whitening” of BAT. Enlarged brown 
adipocytes with few large lipid droplets were found in +/gfp FatED mice, reminiscent of white 
adipocytes filled with a single lipid droplet were also present. In gfp/gfp mice kept on FatED, 
multilocular brown adipocytes were more abundant than in +/gfp FatED mice and comparable 
to BAT cells in ND mice. Due to the coalescence of lipid droplets, the number of lipid 
droplets per brown adipocytes decreased in response to FatED (F(1,14) = 90.99, p < 0.001) - 
but the decrease was moderate in gfp/gfp FatED mice (Fig. 15B). Frequency distribution 
analysis of lipid droplet areas in BAT revealed that  FatED shifted the droplet areas to larger 
sizes, less droplets were under 15 μm2 and more over 135 μm2 (F(1,14) = 8.62, p < 0.05; F 
(1,14) = 16.76, p < 0.01, respectively). In gfp/gfp FatED mice significantly more small lipid 
droplets were present than in +/gfp heterozygotes (Fig. 15C). 
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Figure 15. Quantitative histological analysis of BAT 
A) Representative histological images of hematoxylin-eosin stained BAT sections. FatED fed 
CX3CR1 +/gfp mice have larger lipid droplets. Scale bars = 50 μm. B) Average number of 
lipid droplets / brown adipose cell. C) Frequency distribution of lipid droplet areas in one 
field of view. N = 4-5 per group. * p < 0.05 vs. ND, ** p < 0.01 vs. ND, # p < 0.05 vs. +/gfp, 
## p < 0.01 vs. +/gfp (Newman–Keuls post hoc comparison). FatED – fat enriched diet, ND – 
normal diet. 
 
5.3. Accumulation of macrophages to adipose tissues is fractalkine – CX3CR1 
signaling dependent 
 
Important feature of obesity is the chronic low grade inflammation and accumulation of 
macrophages into adipose tissues. Inflammation in obesity starts in adipose tissue, but affects 
many organs [88]. 
I confirmed with multiple methods that fractalkine – CX3CR1 signaling plays a role in 
macrophage accumulation into adipose tissues:  
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5.3.1. F4/80 Immunohistochemistry 
 
To evaluate the amount of macrophages in the adipose tissues, I performed F4/80 macrophage 
staining and counted the “crown-like structures” (CLS), because >90% of macrophages 
infiltrating the adipose tissue of obese animals and humans are arranged around dead 
adipocytes, forming CLS [89].  
The number of CLS was dramatically increased in the EWAT of obese CX3CR1 +/gfp mice, 
but not in CX3CR1 gfp/gfp mice kept on FatED (diet effect F (1,16) = 18.37, p < 0.001; 
genotype effect F (1,16) = 26.04, p < 0.001; diet*genotype F (1,16) =18.37, p < 0.001). 
Number of CLS in the SWAT of different animals was not significant (Fig. 16).  
 
 
 
Figure 16. Macrophage accumulation to EWAT and SWAT and formation of CLS.  
A) and B) Mean ± SEM values for CLS per field of view in EWAT and SWAT (N = 5 per 
group). C) Representative image of F4/80 immunostained EWAT of +/gfp FatED mouse. 
Adipocytes are surrounded by F4/80 positive macrophages and form CLS. Scale bar = 100 
μm. B) *** p < 0.001 vs. ND, ### p < 0.001 vs. +/gfp (Newman–Keuls post hoc comparison). 
FatED – fat enriched diet, ND – normal diet. 
 
Because little is known about BAT macrophage population, first, fluorescent F4/80 
immunostaining was carried out on GFP expressing BAT blocks to make sure that GFP 
positive cells are similar to those that express the murine macrophage marker F4/80. GFP and 
F4/80 signals completely colocalized (Fig.17). 
 
A) B) C) 
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Figure 17. Colocalization of GFP in CX3CR1 expressing cells with F4/80 in the BAT of 
CX3CR1 +/gfp FatED mouse. 
 
In F4/80 immunostained paraffin embedded BAT sections CLS - similar to those found in 
WAT of obese animals - were observed: enlarged adipocytes filled with single lipid droplet 
were surrounded by numerous immune cells in FatED +/gfp mice. Elevated number of CLS 
was found in BAT in response to FatED (F(1,14) = 21.46, p < 0.001) but only in +/gfp mice 
(Fig. 18).  
 
 
Figure 18. Macrophage accumulation to BAT and formation of CLS 
A) Representative images of F4/80 immunostained BAT. Adipocytes with enlarged lipid 
droplets in the BAT of CX3CR1 +/gfp mice are surrounded by F4/80 positive macrophages 
and form CLS. Scale bar = 50 μm. B) Mean ± SEM values for CLS per mm2 in BAT (N = 5 
per group). *** p < 0.001 vs. ND, ### p < 0.001 vs. +/gfp (Newman–Keuls post hoc 
comparison). FatED – fat enriched diet, ND – normal diet. 
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5.3.2. Gfp mRNA expression 
 
To quantify the recruitment of macrophages in the adipose tissues in response to fat-enriched 
diet, I took advantage of GFP expression in these cells and analyzed normalized Gfp mRNA 
tissue levels. qPCR measurements confirmed the macrophage accumulation both in WAT and 
BAT. In CX3CR1 +/gfp mice, FatED resulted in an increase of Gfp expression, however, in 
CX3CR1 homozygotes the relative quantity of Gfp did not change significantly in response to 
FatED. In BAT the Gfp expression was lower in both diet groups in CX3CR1 gfp/gfp mice 
than in +/gfp mice, and although it slightly elevated in response to FatED (which was not 
significant) it was still the half of Gfp level measured in +/gfp ND mice. These results suggest 
that lack of fractalkine receptor impair the infiltration of CX3CR1+ monocytes into adipose 
tissues (Fig.19). (EWAT: diet effect: F (1,13) = 11.31, p < 0.01; BAT: diet effect: F (1,11) = 
8.68, p < 0.05; genotype effect: F (1,11) = 38.97, p < 0.001). 
 
 
Figure 19. Relative expression of Gfp in EWAT and BAT 
Mean ± SEM values  for relative mRNA levels in EWAT and BAT. N = 4-5 per group. * p < 
0.05, ## < 0.01 , ### < 0.001 vs. +/gfp (Newman-Keuls post-hoc comparison).  FatED – fat 
enriched diet, ND – normal diet. 
 
 
5.3.3. FACS analysis 
 
Monocytes and macrophages in the EWAT have been analyzed by flow cytometry. CX3CR1 
gfp/gfp mice fed normal chow diet showed significantly reduced macrophage numbers overall 
(Fig. 20, p < 0.01, two-way ANOVA), which was most apparent in the F4/80+ MHCIIhigh 
population (p < 0.05, two way ANOVA followed by Sidak’s multiple comparison test) 
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tissues, I have compared their relative expression in mice exposed to ND or FatED. 
Chemokine mRNA levels are shown in Fig. 21 (EWAT) and Fig. 22 (BAT). 
Fractalkine (Cx3cl1) mRNA level was elevated in response to FatED both in WAT and BAT 
independently of genotype (WAT: diet effect F (1,12) = 27.53, p < 0.001; BAT: diet effect: 
F(1,11) = 33.13, p < 0.001), which suggest that absence of the cognate receptor does not affect 
the expression of the ligand in the adipose tissues. 
However Ccl2 showed differences in genotype. Ccl2 expression was over 20 fold higher in 
both adipose tissues of +/gfp FatED mice, while in gfp/gfp FatED group it was significantly 
lower (WAT: diet effect: F (1,14) = 35.89, p < 0.001; genotype effect: F (1,14) = 15.42, p < 
0.01; diet*genotype: F (1,14) = 14.93, p < 0.01; BAT: diet effect: F (1,11) = 9.08, p < 0.05; 
genotype effect: F (1,11) = 7.99, p < 0.05; diet*genotype: F (1,11) = 7.89, p < 0.05). 
 
5.4.2. Inflammatory cytokine expression in adipose tissues  
 
Proinflammatory cytokines (M1 markers): 
As I have detected significant differences in the number of macrophages in the adipose tissues 
of mice exposed to FatED, next, I compared the mRNA levels of proinflammatory cytokines 
produced by macrophages. 
In EWAT FatED increased Il1a, Il1b, Il6 and Tnfa mRNA levels (Fig. 21. diet effect: F (1,13) 
= 29.80, p < 0.001, F (1,13) = 9.17, p < 0.01, F (1,13) = 6.42, p < 0.05, F (1,13) = 79.44, p < 
0.001, respectively). In gfp/gfp FatED mice Il1a, and Tnfa levels were significantly lower than 
in +/gfp fat dieted group. Il6 mRNA level was lower in gfp/gfp mice (genotype effect: F (1,12) 
= 4.71, p < 0.05). Post-hoc analysis did not show differences in mRNA levels. 
Because NALP3 inflammasome is critical in processing pre-proIL1 into releasable form, I 
checked if Nlrp3 (the gene encoding NALP3) gene expression changed in response to FatED 
and/or in the absence of fractalkine signaling. As shown in Fig. 21, FatED resulted in 
elevation of Nlrp3 mRNA levels in EWAT (diet effect: F (1,12) = 41.15, p < 0.001). It has 
also been revealed that FatED induced increase in Nlrp3 mRNA was significantly lower in 
fractalkine receptor deficient mice than that of Cx3CR1 +/gfp animals.  
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Figure 21. Effect of fat-enriched diet on various markers in EWAT.  
Mean ± SEM values  for relative mRNA levels in EWAT. Chemokines: Cx3cl1, Ccl2; 
proinflammatory markers: Il1a, Il1b, Tnfa, Il6, Nlrp3; anti-inflammatory markers: Il10, Arg1. 
N = 4-5 per group. * p < 0.05, ** p < 0.01, *** < 0.0001 vs. ND,  # p < 0.05, ## < 0.01 , ### 
< 0.001 vs. +/gfp (Newman-Keuls post-hoc comparison).  FatED – fat enriched diet, ND – 
normal diet. 
 
FatED upregulated the expression of Il1a, Il1b and Tnfa mRNA levels in BAT (Il1a: diet 
effect: F(1,11) = 11.93, p < 0.01; Il1b: diet effect: F(1,11) = 19.09, p< 0.01; Tnfa: diet effect: F 
(1,11) = 23.75, p < 0.001; genotype effect: F (1,11) = 7.61, p < 0.05) but, according to post-
hoc comparison, it was statistically significant only in +/gfp mice, except Il1b, where the 
elevation was almost significant also in gfp/gfp mice (p = 0.051).  Il1a and Tnfa levels were 
significantly lower in gfp/gfp FatED mice compared to +/gfp FatED mice (Fig. 22). 
 
diet * 
genotype * 
diet * 
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Figure 22. Expression of chemokines and proinflammatory cytokines in BAT.  
Mean ± SEM values for relative mRNA levels in BAT:chemokines: Cx3cl1, Ccl2; 
proinflammatory cytokines: Il1a, Il1b, Tnfa, Il6. N = 3-5 per group. * p < 0.05, ** p < 0.01 
vs. ND, # p < 0.05, ## p < 0.01 vs. +/gfp (Newman–Keuls post hoc comparison). FatED – fat 
enriched diet, ND – normal diet. 
 
Anti-inflammatory cytokines (M2 markers): 
Alternatively activated macrophages (M2) express set of anti-inflammatory cytokines and 
mediators involved in tissue restoration. To address changes in select M2 markers during fat-
enriched dieting, I measured mRNA levels of Il10 and Arg1 in the EWAT. FatED increased 
Il10 and Arg1 mRNA levels (Fig. 21; diet effect: F (1,12) = 21.08, p < 0.001, F (1,12) = 25.68 
p < 0.001, respectively). In gfp/gfp fractalkin receptor knockout mice, Il10 and Arg1 elevation 
was significantly lower than in +/gfp animals following fat-enriched diet. 
Increased levels of Hsd11b1 mRNA were found in the epididymal WAT in both genotypes (F 
(1,14) = 6.92, p < 0.05) as a response to FatED (Fig. 21). 
 
5.5.  10 weeks of FatED does not induce severe inflammation in liver  
 
To investigate whether 10 weeks of FatED induces macrophage accumulation and 
inflammation in liver, I have measured relative quantities of Ccl2, Cx3cl1, Il1a, Il1b and Il6, 
and Tnfa mRNA in liver samples of mice from both genotypes after exposure either normal or 
FatED (Fig. 23). Although Cx3cl1 expression slightly elevated, Ccl2 did not change in 
response to FatED (Cx3cl1: diet effect: F(1,11) = 5.24, p < 0.05). Equal Gfp mRNA levels in 
all groups suggest that macrophages did not accumulate into the liver. Still, elevation in Il1a 
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and Il6 mRNA expression in FatED groups was found (Il1a: diet effect: F(1,12) = 7.50, p < 
0.05; Il6: diet effect: F(1,12) = 7.85, p < 0.05; genotype effect: F(1,12) = 11.63, p < 0.01), but 
post-hoc comparison showed significant elevation only in Il6 in +/gfp mice. Il1b and Tnfa also 
showed a slight elevation in response to diet, but it was not significant (Il1b diet effect: diet 
effect: F(1,12) = 3.83, p = 0.07; Tnfa diet effect: F(1,12) = 3.93, p = 0.07).  
 
Figure 23. Expression of inflammatory markers in liver.  
Mean ± SEM values for relative mRNA levels in liver. N = 4-5 per group. * p < 0.05 vs. ND, # 
p < 0.05 vs. +/gfp (Newman-Keuls post-hoc comparison). FatED – fat enriched diet, ND – 
normal diet.  
 
5.6.  10 weeks of FatED does not induce tissue inflammation in hypothalamus 
 
Inflammatory markers and energy homeostasis regulatory peptides 
 
Neuroinflammation in metabolic-related cell groups of the medial basal hypothalamus has 
been recently detected in high fat fed rodents and obese humans [44].  Normalized Gfp mRNA 
levels in hypothalamus samples showed significant genotype, diet effect, and genotype*diet 
interaction: (F (1,14) = 12.73, p < 0.01; F (1,14) = 4.70, p < 0.05; F (1,14) = 16.41, p < 0.01, 
respectively). Post-hoc analysis revealed increased Gfp mRNA level in FatED fed +/gfp mice, 
but not in gfp/gfp FatED mice. 
Relative Ccl2 mRNA levels were lower in gfp/gfp mice (genotype effect: F (1,14) = 4.77, p < 
0.05) than in the controls (Fig. 24). 
diet * 
diet * 
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There were no significant differences in proinflammatory cytokine mRNA levels (Il1a, Il1b, 
Il6 and Tnfa). Although there was a trend towards a decrease in Il6 mRNA level in CX3CR1 
gfp/gfp mice, it was not statistically significant (genotype effect: F (1,14) = 3.87, p = 0.07). 
Among the hypothalamic metabolic-related neuropeptides, FatED feeding decreased the level 
of orexigenic Npy mRNA level (diet effect: F (1,13) = 16.63, p < 0.01), post-hoc analysis 
showed significant decrease only in gfp/gfp FatED mice compared to gfp/gfp ND mice.   
FatED did not alter anorexigenic Pomc mRNA levels (Fig. 24). 
 
 
 
Figure 24. Expression of inflammatory markers and energy homeostasis regulatory peptides 
in the hypothalamus. 
Mean ± SEM values for relative mRNA levels in hypothalamus. N = 4-5 per group. ** p < 
0.01 vs. ND, ### p < 0.001 vs. +/gfp (Newman-Keuls post-hoc comparison). FatED – fat 
enriched diet, ND – normal diet.  
 
genotype * 
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5.7. Fractalkine - CX3CR1 signaling affects lipolysis/lipogenesis balance in 
BAT 
 
To analyze whether differences in lipid metabolism contribute to diet-induced phenotypic- and 
morphological changes in BAT of +/gfp and gfp/gfp animals, I have measured expression of 
enzymes involved in lipid synthesis and lipolysis in the BAT.  
FatED upregulated lipogenic enzymes, Dgat1 and Gpat mRNA expression in both genotypes, 
although elevation in Dgat1 expression was statistically significant only in gfp/gfp mice, 
according to post-hoc analysis (p = 0.07 between +/gfp groups). There were no statistically 
significant differences in Mgat mRNA levels. Lipolytic enzyme expression (Atgl, Hsl, Mgl) 
did not change in response to FatED in +/gfp mice. Gfp/gfp ND fed mice express lower levels 
of Atgl and Mgl than +/gfp ND mice, and FatED upregulated all lipolytic enzymes’ mRNA 
expression (Fig. 25) (Lipogenic enzymes: Dgat1 (diet effect: F (1,13) = 76.94, p < 0.001); 
Gpat (diet effect: F (1,13) = 129.54, p < 0.001; diet * genotype: F (1,13) = 12.44, p < 0.01). 
Lipolytic enzymes: Atgl (diet effect: F (1,13) = 22.12, p < 0.001; diet * genotype: F (1,13) = 
6.64, p < 0.05); Hsl (diet effect: F (1,13) = 18.02, p < 0.001; diet * genotype: F (1,13) = 20.04, 
p < 0.001); Mgl (diet effect: F (1,13) = 32.10, p < 0.001; diet * genotype: F (1,13) = 9.07, p < 
0.05)). 
 
Figure 25. Gene expression of lipogenic and lipolytic enzymes in the BAT.    
Lipogenic enzymes: top row, lipolytic enzymes, bottom row. Mean ± SEM values for relative 
mRNA levels in BAT. N = 4-5 per group. * p < 0.05, ** p < 0.01, *** p < 0.0001 vs. ND, # p 
< 0.05, ## p < 0.01 vs. +/gfp (Newman–Keuls post hoc comparison). FatED – fat enriched 
diet, ND – normal diet.  
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5.8. Fractalkine – CX3CR1 signaling affects the expression of BAT 
thermogenic and metabolic-related markers  
 
Because BAT significantly contributes to energy expenditure via non-shivering thermogenesis 
by using fatty acids and glucose as fuels, next I investigated the diet-induced expression of 
thermogenesis-related markers in the BAT of mice with or without fractalkine signaling. 
In +/gfp mice, fat enriched diet did not affect expression of Ucp1, Pparg2 and Pgc1a, 
however, Dio2 and Adrb3 mRNA levels were elevated. Gfp/gfp mice express less Ucp1, 
Pparg2 and Pgc1a mRNA, than +/gfp mice under normal diet, exposure to FatED resulted in 
significantly elevated expression of these mRNAs in the BAT.  Pparg2 and Adrb3 mRNA 
levels in gfp/gfp FatED mice was higher than in +/gfp FatED mice (Fig. 26) (Ucp1: diet 
effect: F (1,11) = 23.68, p < 0.001; genotype * diet: F (1,11) = 13.74, p < 0.01; Pparg2: diet 
effect: F (1,11) = 26.88, p < 0.001, genotype * diet: F (1,11) = 43.91, p < 0.001; Pgc1a: diet 
effect: F(1,11) = 15.74, p < 0.01; genotype * diet: F (1,11) = 7.75, p < 0.05. Dio2: diet effect: 
F (1,11) = 24.70, p < 0.001; genotype effect: F (1,11) = 17.35, p < 0.01. Adrb3: diet effect: F 
(1,11) = 89.78, p < 0.001; genotype effect: F (1,11) = 7.56, p < 0.05; genotype * diet: F (1,11) 
= 28.23, p < 0.001).  
Because adipose tissue macrophages synthesize and release catecholamines locally in response 
to cold [90], I have been interested how tyrosine hydroxylase (Th), the key enzyme in 
catecholamine synthesis, varies in the BAT in response to diet. Neither the genotype nor the 
diet affected Th mRNA expression in the BAT. 
DOI:10.15774/PPKE.ITK.2017.003
49 
 
 
 
Figure 26. Gene expression of BAT thermogenic and metabolic-related markers.  
Mean ± SEM values for relative mRNA levels in BAT. N = 4-5 per group.  * p < 0.05, ** p < 
0.01, *** p < 0.001 vs. ND; # p < 0.05, ## p < 0.01 ###, p < 0.001 vs. +/gfp (Newman–Keuls 
post hoc comparison). FatED – fat enriched diet, ND – normal diet.  
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5.9. FatED results in elevated UCP1 protein levels in fractalkine deficient 
mice 
 
Using Western blot analysis I showed that FatED did not change UCP1 protein levels in +/gfp 
FatED mice. On the contrary, FatED resulted in elevated UCP1 levels in gfp/gfp animals (Fig. 
27). The difference seen in Ucp1 mRNA levels between ND groups was not recognized at 
protein level. 
 
Figure 27. UCP1 protein levels in BAT. A) Representative Western blot image. B) Mean ± 
SEM values for relative density of UCP1 in BAT. N = 3 per group. * p < 0.05 vs. ND; # p < 
0.05 vs. +/gfp (Newman–Keuls post hoc comparison). FatED – fat enriched diet, ND – normal 
diet.  
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6. Discussion 
 
Present results show the importance of fractalkine – CX3CR1 signaling in the development of 
obesity. Mice with normal fractalkine signaling (CX3CR1 +/gfp) on FatED gain significant 
body weight by storing excess fat in the adipose tissues. Not only the hypertrophy of white 
adipocytes in EWAT and SWAT was observed, but remodeling and “whitening” of BAT. 
Adipocyte hypertrophy was associated with recruitment of macrophages, formation of CLS 
and expression of inflammatory cytokines both in WAT and BAT. Because of the remodeling 
and inflammatory environment, thermogenesis in BAT was impaired, therefore the decreased 
energy expenditure and the elevated fat intake and storage led to obesity, chronic low grade 
inflammation, glucose intolerance and cold intolerance. Lack of fractalkine signaling 
prevented macrophage accumulation into adipose tissues and consequently, the inflammatory 
cytokine expression. Furthermore, with the lack of macrophages and inflammation, 
thermogenic capacity in BAT was upregulated, therefore the elevated energy expenditure 
could compensate the increased fat intake, and decrease body weight gain. 
 
High fat diet is a major environmental factor that triggers obesity both in humans and in 
rodents [91]. There are several diets and paradigms to induce obesity. Among these, I used fat-
enriched food which has been shown to be a relevant trigger for obesity and related 
pathologies [92-95]. To exclude any food preference, a mixture of chow and lard was given.  
Heterozygous (CX3CR1 +/gfp) FatED animals with intact fractalkine signaling started to gain 
more weight than mice on ND and the difference in body weight became significant after 
week 5. This time course is comparable to those obtained after various high fat diets [96-100].  
By contrast, mice - in which fractalkine signaling is compromised -, gain much less weight 
when on fat-enriched diet than heterozygotes (even though their energy intake and fecal output 
was equal). These results and the normal glucose tolerance and plasma cytokine levels suggest 
that CX3CR1 gfp/gfp mice are somehow resistant to diet-induced obesity.  
In heterozygote (CX3CR1 +/gfp) mice, changes in body weight were accompanied with 
increases in body fat depots. Notably, EWAT and BAT was also enlarged in CX3CR1 gfp/gfp 
mice, but the increase was significantly less than that seen in animals with +/gfp genotype.  
My results on diet-induced obesity in CX3CR1 gfp mice differ from other reports on this 
model. For instance, Morris et al [73] and Lee et al [101] and Shah et al [102] failed to detect 
differences in HFD induced body weight and adiposity in fractalkine receptor KO mice and 
controls. These discrepancies might be due to the different composition of high fat diet (20% 
protein, 20% carbohydrate and 60% fat for Morris and Lee; 20% protein, 35% carbohydrate, 
45% fat for Shah; 9,7% protein, 28% carbohydrate and 62,3% fat in my studies), duration of 
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the diet (30 weeks for Morris, 24 weeks for Lee, 4-24 for Shah and 10 weeks in this study), 
different hygienic status of the animal facility (SPF for Morris and Shah, MD in my studies), 
or strain differences (CX3CR1KO for Lee vs. CX3CR1gfp in my studies). The hygienic status 
of the animal facility might be important in DIO models, as gut microbiota plays pivotal role 
in the development of obesity [103-105].  Moreover, in a study comparing DIO in 
conventional and SPF animal facilities, only conventional DIO mice were characterized by 
metabolic endotoxemia and low-grade inflammation [106]. 
 
Activity of the hypothalamo-pituitary-adrenocortical axis in general, and corticosterone 
plasma levels in particular have been shown to contribute to regulation of abdominal fat 
deposition [92, 107].   Data on high fat diet-induced corticosterone concentrations are highly 
controversial: there are reports on increase, decrease or unchanged levels (see [108] for 
review). Here I found a tendency for FatED-induced adrenocortical hyperactivity in both 
genotypes. At cellular level, corticosteroid action is dependent on the activity of type1, 11beta-
hydroxysteroid dehydrogenase (HSD11B1) which converts inactive corticosteroids into active 
corticosterone in mice. In contrast to previous view [109], recent data support the main effect 
of high fat diet-induced adipose specific HSD11B1 downregulation promoted fat 
accumulation [110]. Furthermore, high local concentration of corticosterone in adipose tissue 
and/or elevated plasma concentration in CX3CR1 gfp/gfp mice might reduce macrophage 
production of proinflammatory cytokines and promote anti-inflammatory responses [111].  
 
 
Both type of adipose tissue displays significant morphological and functional plasticity driven 
by metabolic-, environmental- and hormonal cues [112]. “Browning” of the white adipose 
tissue is well recognized. For instance, clusters of UCP1 expressing cells referred to as “brite” 
(brown in white or beige) adipocytes appear in the white adipose tissue in response to cold, 
while there is a downregulation of Ucp1 mRNA levels together with phenotypic appearance of 
white adipocytes in the BAT at thermoneutral conditions [113]. Here I have shown 
„whitening” of BAT in response to fat-enriched diet in mice, which is due to coalescence of 
lipid droplets. Similar, distorted lipid droplet architecture has also been reported in mice kept 
on high fat diet for 13 weeks [114, 115]. Increase of the size of lipid droplets might indicate an 
imbalance between lipid synthesis and lipolysis. Indeed, present results show that lipogenic 
enzymes expression were upregulated in both FatED groups, while lipolytic enzymes were 
upregulated only in gfp/gfp mice, which might be responsible for less fat deposition in BAT of 
these animals.  
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Analysis of resident macrophage population in the white adipose tissue of intact animals 
revealed significantly less macrophages with F4/80+MHCII high phenotype in CX3CR1 
gfp/gfp animals than in CX3CR1 +/gfp heterozygotes.    
 
In addition to morphological changes of adipocytes I found recruitment/accumulation of 
mononuclear cells into the WAT and BAT of +/gfp mice kept on fat-enriched diet. Number of 
CLS is a good indicative of the infiltrated macrophages in WAT as > 90% of them are found 
in these structures [89]. In EWAT of obese +/gfp animals significantly higher number of CLS 
was found than in CX3CR1 gfp/gfp mice on FatED. CLS formation in the SWAT of FatED 
fed mice was not significant, which is in accordance with other experiments, where CLS were 
less prevalent in subcutaneous than in visceral fat [116]. However CLS in BAT is not 
documented. I found CLS – similar to those found in the EWAT of obese animals - surround 
enlarged BAT cells with distorted lipid droplets.  Beyond the immunohistochemical analysis 
of CLS, I confirmed macrophage accumulation by qPCR measurement of Gfp mRNA in the 
tissues. Fat-enriched diet resulted in an increase of normalized Gfp mRNA expression in the 
EWAT, BAT, liver and hypothalamus in animals with intact fractalkine signaling, indicative 
of selective recruitment and/or activation of cells expressing CX3CR1/gfp. Indeed, obesity 
induces infiltration of macrophages into the epididymal fat, the adipose tissue macrophage 
content correlates with the measures of obesity and cytokines released from these cells 
contribute to the insulin resistance of the adipocytes [40, 117].  
These data are also consistent with previous results showing that genetic and diet-induced 
obesity results in chronic inflammation in the BAT [118-120]. By contrast, Fitzgibbons et al. 
found very low level of immune cell enriched transcripts in the BAT from C57BL6/J mice fed 
a high-fat diet for 13 weeks [114]. Thus the extent of BAT inflammation is largely depends on 
the strain and conditions used.  
 
Recruitment of leukocytes into the white adipose tissue and their role in metabolic 
inflammation is well recognized both in genetic- and diet-induced rodent models as well as in 
human obesity [121]. Feeding a high fat diet to C57Bl6 mice has been shown to promote large 
increases of various leukocytes, among those T cells and neutrophils are the first on the scene, 
followed by monocytes/macrophages by 8-10 weeks on diet [122]. Adipose tissue 
macrophages have been mechanistically implicated in low grade, long lasting, metabolic 
inflammation and glucose intolerance seen in diet-induced obesity [117, 123]. It has been 
hypothesized that dying adipocytes initiate macrophage recruitment to the adipose tissue, 
however, recent findings emphasize the role of various chemokines originating from 
adipocytes and/or from the stromal vascular fraction. In this respect the monocyte attractant 
protein, CCL2 (MCP1) and its receptor CCR2 have been the most intensively studied [124]. 
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Although Mcp1 mRNA level in the adipose tissue is elevated within 7 days and plasma MCP1 
concentration increased 4 weeks after starting high fat diet, genetic disruption of MCP1 
signaling did not confer resistance to diet-induced obesity in mice or reduce adipose tissue 
macrophage infiltration in the WAT [124], indicating involvement of additional monocyte 
attractants.   
One interesting finding of the present study is the lack of diet-induced elevation of Ccl2 
(Mcp1) in fractalkine receptor deficient mice, suggesting some mechanistic relationship 
between these chemokines. 
 
Recent results of Shah et al in humans [56] demonstrated that fractalkine (CX3CL1)  is 
significantly increased in obesity and revealed adipocytes and stromal vascular fraction as 
source of this adipochemokine that mediates monocyte adhesion to human adipocytes. 
Fractalkine is implicated in recruitment of leukocytes in clinical syndromes of adipose tissue 
inflammation and atherosclerosis. Here I have confirmed upregulation of fractalkine 
transcription in the adipose tissue of mice on fat-enriched diet and identified the fractalkine 
receptor CX3CR1 as an important mediator of monocyte/macrophage recruitment into the 
visceral fat in obesity. Furthermore I reported, for the first time, that fat enriched diet induces 
fractalkine expression in brown adipose tissue as well. This scenario shows similarities with 
mouse models of atherosclerosis, where disruption of either CX3CL1 or CX3CR1 attenuates 
macrophage trafficking and inflammation [125-127] . By contrast, Morris et al did not find 
differences in total adipose tissue macrophages (ATM), in the ratio of type 1 (CD11c(+)) to 
type 2 (CD206(+)) ATMs, expression of inflammatory markers, and T-cell content in 
epididymal fat from obese CX3CR1(+/gfp) and CX3CR1(gfp/gfp) mice [73]. Beside the 
differences in housing and dieting conditions, these discrepancies raise a relevant possibility 
that cells attracted to the adipose (target) tissue downregulate their special surface markers.   
Based on the facts that expression of fractalkine has been significantly elevated in all groups 
fed with FatED, while mice lacking the fractalkine receptor accumulated significantly less 
GFP+ cells into the BAT and display less severe local tissue inflammation than controls, I 
propose a role of fractalkine/fractalkine receptor system in recruitment of macrophages into 
the BAT.  
CLS are regarded as a major source of proinflammatory cytokines in the inflamed fat tissue. 
Indeed, my data demonstrate upregulation of proinflammatory cytokines Il1a, Il1b and Tnfa 
expression in the EWAT and BAT of control mice (CX3CR1 +/gfp) in response to fat-
enriched diet. This effect was attenuated in CX3CR1 gfp/gfp mice, supporting the hypothesis 
that fractalkine signaling is involved in the activation/polarization of adipose tissue 
macrophages in obesity [95, 117]. However, the specific leukocyte/macrophage population, 
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which contributes to the local elevation of proinflammatory cytokines in the fat challenged 
adipose tissue, remains to be elucidated.  
Processing of pro IL1b by the NLRP3 inflammasome has recently been implicated in obesity 
[128]. Here I have revealed an increase of Nlrp3 mRNA within the epididymal fat pad of 
CX3CR1 +/gfp mice fed with fat-enriched diet that might contribute to an elevated tissue 
levels of Il1b. There are several danger-associated signals that might induce assembly of 
NLRP inflammasome and sterile inflammation of the visceral fat in obese subjects. For 
instance, ceramide and palmitate have been implicated in activation and /or priming of the 
inflammasome in adipose tissue and macrophages [129].   
Accumulation of proinflammatory macrophages in obese adipose tissues shows similarities to 
foam cell formation in atherosclerotic plaques, which is also dependent on the presence of 
CX3CR1 [125]. It should be recognized, however, that different subsets of monocytes use 
different chemokine patterns with which to accumulate in various inflammatory targets [130].  
It has been shown previously that adipose tissue macrophages in lean animals express markers 
characteristic of alternatively polarized (M2) macrophages, while high fat diet-induced obesity 
results in a phenotypic change to M1 polarization [41].  
In addition to proinflammatory cytokines, I have demonstrated significant upregulation of two 
anti-inflammatory markers Il10 and Arg1 mRNA in WAT samples from CX3CR1 +/gfp 
animals kept on fat-enriched diet, which can be interpreted as a local compensatory 
mechanism [131, 132]. It should be noted however, that neither baseline expression, nor diet-
induced upregulation of Il10 and Arg1 transcription is significant in mice with impaired 
fractalkine signaling.  
Among the cytokines induced by FatED in the BAT, TNFa might play a prominent role in 
morphofunctional rearrangements. For instance, TNFa decreased the expression of 
functionally active ADRB3 receptors in brown adipocytes and consequently attenuated the 
thermogenic and lipolytic actions of sympathetic nervous system (SNS) activity [133]. Studies 
on 3T3-L1 adipocytes revealed that TNFa attenuates expression of lipolytic enzymes Atgl and 
Hsl [134]. Conversely, TNFa deficiency in genetically obese (ob/ob) mice resulted in less 
severe obesity, decrease in brown adipocyte apoptosis, and increased expression of Adrb3 and 
Ucp1 with significant improvement of thermogenetic capacity [133]. Fractalkine receptor 
deficient mice (gfp/gfp), in which FatED- did not induce local Tnfa expression, are protected 
from excessive weight gain, display improved glucose tolerance and induction of Adrb3, Atgl 
and Hsl mRNA in the BAT. 
The next obvious question was how FatED-induced proinflammatory environment affects 
energy expenditure/cold tolerance and BAT expression of metabolic-related and thermogenic 
genes. CX3CR1 +/gfp mice do not increase BAT expression of Ucp1, Pparg2, and Pgc1a in 
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response to FatED, which might explain their obesity prone phenotype and impaired cold 
tolerance during fat enriched diet. Indeed, it has been recently shown that macrophage derived 
proinflammatory cytokines in general-, and TNFa in particular, suppress the induction of Ucp1 
promoter activity and mRNA expression [135, 136]. Diet-induced differences of UCP1 protein 
in the BAT of +/gfp and gfp/gfp of mice has been confirmed at protein level, however the 
mismatch seen in normal dieted mice between Ucp1 mRNA, UCP1 protein levels and cold 
tolerance might be related to different mRNA stability and/or differences in the 
hormone/cytokine milieu and needs further investigation. By contrast, it is interesting to 
recognize that Dio2 expression was slightly increased in the BAT of obese FatED +/gfp mice. 
Increased DIO2 activity would have resulted in elevated local levels of T3 and induce UCP-
driven thermogenesis. Nevertheless, the interaction between various hormonal- (T3, 
corticosteroids, insulin) autonomic- (sympathetic drive) and inflammatory cytokines and 
adipocytes is quite complex and occurs at several functionally distinct loci of obesity.    
Present data demonstrate that fat-enriched diet-induced proinflammatory cytokine expression 
is limited to the adipose tissues, because Il1a, Il1b and Tnfa mRNA levels did not change in 
the liver and in the hypothalamic samples. In contrast, Thaler et al [44] reported a HFD-
induced bi-phasic hypothalamic inflammation in rats, the first occurs shortly after starting the 
diet and the second observed in response to chronic HFD exposure. It remains unknown 
whether our fat-enriched diet is less obesogenic/immunogenic than other high fat diets and/or 
the length of the exposure was insufficient to induce widespread central inflammation. For 
instance, ApoE-/- mice kept on highly atherogenic cholate/cholesterol rich diet (Paigen) lose 
weight and develop vascular inflammation, microglial activation, and leukocyte recruitment in 
the brain, while those mice that are on fatty Western style diet gain weight and show 57% 
lower vascular inflammation in the brain [137]. 
Among the hypothalamic energy homeostasis regulating peptides, the expression of orexigenic 
Npy decreased in FatED fed mice, which can be regarded as compensatory mechanisms to 
defend body weight. Inhibition of Npy and Agrp expression is also observed in response to 
leptin and insulin, which are long-term adiposity signals [138-140].  Nevertheless Pomc 
expression did not change in response to FatED.  
 
In summary, I report that mice with impaired fractalkine signaling are protected from fat-
enriched diet-induced obesity. The mechanism might involve altered lipolysis/lipogenesis 
balance in adipose tissues and altered thermogenesis as a result of impaired recruitment of 
leukocytes/monocytes to adipose tissues. 
These results suggest also that diet-induced recruitment of macrophages in the BAT of +/gfp 
mice through the release of proinflammatory cytokines like TNFa, results in local 
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inflammation and may attenuate the sympathetic nervous system (SNS) induced 
thermogenesis and lipolysis in adipose tissues, leading to fat accumulation, driving a vicious 
circle. However, impaired fractalkine signaling (in gfp/gfp mice) breaks this circle by 
attenuating the accumulation of adipose tissue macrophages and their cytokine production, 
which results in diet-induced upregulation of Atgl, Hsl and Mgl lipolytic enzymes and Ucp1 
mRNA and protein in the BAT. These changes are likely to contribute to the improved 
thermoadaptive response and the leaner phenotype seen in fractalkine receptor deficient mice 
(Fig.28).  
These results open new avenues for CX3CR1 antagonists to fight obesity and metabolic 
inflammation-related pathologies.   
 
 
Figure 28. Fractalkine and CX3CR1 contributes to the accumulation of macrophages into 
BAT during the development of obesity. The presence of macrophages leads to elevated 
expression of proinflammatory cytokines, which attenuate the thermogenic capacity of BAT. 
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7. New scientific results 
Thesis I.  
I have shown that FatED induced obesity and metabolic inflammation is associated with 
elevated fractalkine expression in WAT and BAT 
I have found that 
 10 weeks of fat enriched diet (FatED) results in increased body weight gain in mice. 
 Body weight gain/obesity is due to increased fat deposition 
 Obese mice display glucose and cold intolerance. 
 FatED results in morphological rearrangements and recruitment of 
leukocytes/macrophages in white and brown adipose tissue depots. 
 Obese mice have metabolic inflammation with  
o increased plasma levels of proinflammatory cytokine IL1b;  
o increased mRNA levels of chemokines in white and brown adipose tissue;  
o elevated local expression of proinflammatory cytokines in the WAT and BAT. 
 I have shown for the first time that FatED results in fractalkine mRNA induction in 
the BAT; 
 FatED-induced inflammation was localized in the adipose tissues but not seen in the 
liver or in the hypothalamus. 
 
Thesis II.  
I have shown that fractalkine – CX3CR1 signaling contributes to the development of 
obesity 
Because fractalkine-fractalkine receptor system is involved in the signaling, trafficking, 
recruitment and activation of various leukocytes at the site of inflammation, I have 
investigated its involvement in metabolic inflammation.  
 
I have provided new evidence that mice with targeted disruption of the fractalkine receptor 
(CX3CR1) gene (CX3CR1 gfp/gfp) 
 are less sensitive to obesogenic effect of FatED;  
 gain less weight on FatED and do not develop glucose intolerance during the diet; 
 their adipocytes are smaller and display significantly less crown like structures in the 
epididymal WAT and BAT; 
 have equally increased expression of fractalkine, but decreased Ccl2 expression;  
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 recruit much less GFP+ and F4/80+ macrophages in the WAT and BAT when kept on 
FatED; 
 display attenuated expression of proinflammatory cytokines in the epididymal WAT 
and BAT; 
 do not develop serious metabolic inflammation – 
 
- compared to CX3CR1 heterozygotes, which have intact fractalkine signaling.  
 
 
Thesis III.  
I have shown that obesity associated fractalkine – CX3CR1 dependent macrophage 
infiltration and inflammation in BAT affects thermogenesis 
I have found that the obesity resistant phenotype of fractalkine receptor deficient mice is 
mechanistically associated with  
 increased lipolysis due to diet-induced expression of lipolytic - and unchanged 
lipogenic enzymes;  
 and increased expression of uncoupling protein (UCP1) in the BAT –  
- which was not seen in obese mice with normal fractalkine signaling. 
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8. Possible applications 
 
My new scientific results contribute to the understanding of the development of obesity, 
metabolic inflammation and control of thermogenesis in BAT. Using this knowledge, new 
potential therapeutic targets can be identified. First of all, pharmacological inhibition of 
fractalkine receptor by CX3CR1 antagonist could reduce macrophage accumulation to adipose 
tissues, therefore reduce adipose tissue inflammation and the development of obesity. 
Treatment with F1, a CX3CR1 antagonist, has been shown to reduce macrophage 
accumulation in the aortic sinus in mouse models of atherosclerosis [141], thus its use in 
obesity is promising. Based on my research, though a CX3CR1 antagonist could prevent the 
development of obesity if it is administered from onset, it requires further investigation 
whether it could reduce obesity when it is administered in advanced state. Second, BAT, as an 
important contributor of energy expenditure by non-shivering thermogenesis, could be a 
potential therapeutic target. Preventing macrophage accumulation thus preventing 
proinflammatory cytokine expression in BAT, or blocking the proinflammatory cytokine 
expression in BAT could upregulate the thermogenic machinery therefore the elevated 
thermogenic activity could modulate energy intake/energy expenditure balance leading to the 
utilization of excess fat. In an experiment in mice it has been shown that cold exposure rapidly 
promotes alternative activation of adipose tissue macrophages, which secrete catecholamines 
to induce thermogenic gene expression in BAT and lipolysis in WAT [90]. My results suggest 
that the proinflammatory environment is responsible for the impaired thermogenesis in obese 
animals. Accordingly setting a cold therapy protocol in humans, which could induce switching 
of macrophages from proinflammatory to alternatively activated state, could activate BAT 
thermogenesis in obese people potentially leading to weight loss. 
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